4.7 Article

Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine

Ting Li et al.

Summary: PDAC is a lethal cancer with poor survival rates due to poor treatment response. The study identified S100A16 as a potential therapeutic target for PDAC treatment, showing its correlation with poor prognosis and role in promoting cancer cell metastasis through EMT and TWIST1/STAT3 signaling pathway.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Cell Biology

S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways

Dan Fang et al.

Summary: The S100A16 gene, located on chromosome 1q21, is significantly upregulated in pancreatic ductal adenocarcinoma (PDAC) samples. It promotes PDAC progression through FGF19-mediated AKT and ERK1/2 signaling, indicating S100A16 as a promising therapeutic target for PDAC.

CELL BIOLOGY AND TOXICOLOGY (2021)

Article Oncology

S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway

Shiyu Ou et al.

Summary: The study revealed that S100A16 suppressed the proliferation, migration, and invasion of CRC cells partially through the JNK/p38 MAPK signaling pathway and subsequent EMT mediation.

MOLECULAR MEDICINE REPORTS (2021)

Article Genetics & Heredity

High expression of MYEOV reflects poor prognosis in non-small cell lung cancer

Rui Zhang et al.

Summary: MYEOV is overexpressed in NSCLC and is associated with prognosis and immune infiltration, indicating it can serve as a prognostic biomarker for NSCLC.
Article Multidisciplinary Sciences

Pancancer survival analysis of cancer hallmark genes

Adam Nagy et al.

Summary: This study aimed to estimate the prognostic effect of cancer hallmark genes in multiple distinct cancer types. The results showed significant heterogeneity and tissue specificity in the correlation between these genes and survival, providing valuable information for future targeted therapy development in solid tumors.

SCIENTIFIC REPORTS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biochemistry & Molecular Biology

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Li Ding et al.

Article Biochemistry & Molecular Biology

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Francisco Sanchez-Vega et al.

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Dentistry, Oral Surgery & Medicine

Site-Specific Neutrophil Migration and CXCL2 Expression in Periodontal Tissue

A. Greer et al.

JOURNAL OF DENTAL RESEARCH (2016)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Article Oncology

Pancreatic Cancer Database An integrative resource for pancreatic cancer

Joji Kurian Thomas et al.

CANCER BIOLOGY & THERAPY (2014)

Article Multidisciplinary Sciences

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin et al.

NATURE (2012)

Article Biochemical Research Methods

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Cole Trapnell et al.

NATURE PROTOCOLS (2012)

Article Oncology

MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2

Garrett Lawlor et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)

Article Multidisciplinary Sciences

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Sian Jones et al.

SCIENCE (2009)